Recombinant Visfatin Antibody

抗体

内脂素/内脏脂肪素/前B细胞克隆增强因子1抗体 | 内脂素/内脏脂肪素/前B细胞克隆增强因子1单克隆抗体 | 内脂素/内脏脂肪素/前B细胞克隆增强因子1重组单克隆抗体 | Visfatin抗体 | Visfatin单克隆抗体 | Visfatin重组单克隆抗体 | NAMPT抗体 | NAMPT单克隆抗体 | NAMPT重组单克隆抗体

1110035O14Rik antibody | AI314458 antibody | AI480535 antibody | DKFZP666B131 antibody | EC 2.4.2.12 antibody | MGC117256 antibody | NAmPRTase antibody | Nampt antibody | NAMPT_HUMAN antibody | Nicotinamide phosphoribosyltransferase antibody | PBEF antibo

Liquid

Ab134271-10μl

10μl

重组

见COA

-20°C储存,避免反复冻融

超低温冰袋运输

4°C 短期储存（1-2 周）。-20°C下长期保存（24个月）。收货后建议分装。避免冷冻/解冻循环。

50mM Tris-Glycine, 150mM NaCl, 40% Glycerol, 0.05% BSA, 0.01% Sodium azide, pH 7.4

0.01% Sodium azide

Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway.

A synthetic peptide derived from human Visfatin (AA 330-349)

兔(Rabbit)

人(Human), 大鼠(Rat), 小鼠(Mouse) | 人(Human),大鼠(Rat),小鼠(Mouse)

NAMPT

WB: HeLa, U-2 OS, Raji and C6 cell lysates. IHC: Human lung cancer tissue. ICC/IF: U87-MG cells.

150 kDa

Unconjugated

Rabbit IgG

重组抗体

kappa

Protein A purified

Whole IgG